202 related articles for article (PubMed ID: 33714064)
21. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
Weise P; Apel P; Kolossa-Gehring M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative.
Vorkamp K; Castaño A; Antignac JP; Boada LD; Cequier E; Covaci A; Esteban López M; Haug LS; Kasper-Sonnenberg M; Koch HM; Pérez Luzardo O; Osīte A; Rambaud L; Pinorini MT; Sabbioni G; Thomsen C
Environ Int; 2021 Jan; 146():106082. PubMed ID: 33227583
[TBL] [Abstract][Full Text] [Related]
23. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
[TBL] [Abstract][Full Text] [Related]
24. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for cadmium and its compounds.
Lamkarkach F; Ougier E; Garnier R; Viau C; Kolossa-Gehring M; Lange R; Apel P
Environ Int; 2021 Feb; 147():106337. PubMed ID: 33385924
[TBL] [Abstract][Full Text] [Related]
25. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
[TBL] [Abstract][Full Text] [Related]
26. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
[TBL] [Abstract][Full Text] [Related]
27. Quality assurance and harmonization for targeted biomonitoring measurements of environmental organic chemicals across the Children's Health Exposure Analysis Resource laboratory network.
Kannan K; Stathis A; Mazzella MJ; Andra SS; Barr DB; Hecht SS; Merrill LS; Galusha AL; Parsons PJ
Int J Hyg Environ Health; 2021 May; 234():113741. PubMed ID: 33773388
[TBL] [Abstract][Full Text] [Related]
28. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.
Apel P; Lamkarkach F; Lange R; Sissoko F; David M; Rousselle C; Schoeters G; Kolossa-Gehring M
Int J Hyg Environ Health; 2023 Mar; 248():114097. PubMed ID: 36577283
[TBL] [Abstract][Full Text] [Related]
29. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP).
David M; Gerofke A; Lange R; Kolossa-Gehring M; Apel P
Int J Hyg Environ Health; 2021 Sep; 238():113856. PubMed ID: 34619432
[TBL] [Abstract][Full Text] [Related]
30. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
[TBL] [Abstract][Full Text] [Related]
31. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
32. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
[TBL] [Abstract][Full Text] [Related]
33. A step towards harmonising human biomonitoring study setup on European level: Materials provided and lessons learnt in HBM4EU.
Pack LK; Gilles L; Cops J; Tolonen H; van Kamp I; Esteban-López M; Pedraza-Díaz S; Lacasaña M; Alzaga BG; Lermen D; Bartel-Steinbach M; Katsonouri A; Fiddicke U; Castaño A; Kolossa-Gehring M
Int J Hyg Environ Health; 2023 Apr; 249():114118. PubMed ID: 36773579
[TBL] [Abstract][Full Text] [Related]
34. Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results.
Ougier E; Ganzleben C; Lecoq P; Bessems J; David M; Schoeters G; Lange R; Meslin M; Uhl M; Kolossa-Gehring M; Rousselle C; Vicente JL
Int J Hyg Environ Health; 2021 Jul; 236():113778. PubMed ID: 34089975
[TBL] [Abstract][Full Text] [Related]
35. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU.
Santonen T; Mahiout S; Alvito P; Apel P; Bessems J; Bil W; Borges T; Bose-O'Reilly S; Buekers J; Cañas Portilla AI; Calvo AC; de Alba González M; Domínguez-Morueco N; López ME; Falnoga I; Gerofke A; Caballero MDCG; Horvat M; Huuskonen P; Kadikis N; Kolossa-Gehring M; Lange R; Louro H; Martins C; Meslin M; Niemann L; Díaz SP; Plichta V; Porras SP; Rousselle C; Scholten B; Silva MJ; Šlejkovec Z; Tratnik JS; Joksić AŠ; Tarazona JV; Uhl M; Van Nieuwenhuyse A; Viegas S; Vinggaard AM; Woutersen M; Schoeters G
Int J Hyg Environ Health; 2023 Apr; 249():114139. PubMed ID: 36870229
[TBL] [Abstract][Full Text] [Related]
36. Useful and Fast Method for Blood Lead and Cadmium Determination Using ICP-MS and GF-AAS; Validation Parameters.
Trzcinka-Ochocka M; Brodzka R; Janasik B
J Clin Lab Anal; 2016 Mar; 30(2):130-9. PubMed ID: 25425387
[TBL] [Abstract][Full Text] [Related]
37. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
Galea KS; Porras SP; Viegas S; Bocca B; Bousoumah R; Duca RC; Godderis L; Iavicoli I; Janasik B; Jones K; Knudsen LE; Leese E; Leso V; Louro H; Ndaw S; Ruggieri F; Sepai O; Scheepers PTJ; Silva MJ; Wasowicz W; Santonen T
Int J Hyg Environ Health; 2021 May; 234():113725. PubMed ID: 33714856
[TBL] [Abstract][Full Text] [Related]
38. Harmonized Quality Assurance/Quality Control Provisions for Nontargeted Measurement of Urinary Pesticide Biomarkers in the HBM4EU Multisite SPECIMEn Study.
Vitale CM; Lommen A; Huber C; Wagner K; Garlito Molina B; Nijssen R; Price EJ; Blokland M; van Tricht F; Mol HGJ; Krauss M; Debrauwer L; Pardo O; Leon N; Klanova J; Antignac JP
Anal Chem; 2022 Jun; 94(22):7833-7843. PubMed ID: 35616234
[TBL] [Abstract][Full Text] [Related]
39. The questionnaire design process in the European Human Biomonitoring Initiative (HBM4EU).
González-Alzaga B; Hernández AF; Kim Pack L; Iavicoli I; Tolonen H; Santonen T; Vinceti M; Filippini T; Moshammer H; Probst-Hensch N; Kolossa-Gehring M; Lacasaña M
Environ Int; 2022 Feb; 160():107071. PubMed ID: 34979351
[TBL] [Abstract][Full Text] [Related]
40. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
